<2> Space Drugs: Why the UK Government Wants to Head into Orbit to Make Medicines
<3> A New Frontier in Pharmaceutical Manufacturing
The UK government has announced a new initiative aimed at enhancing the manufacturing of pharmaceuticals in space. This ambitious project seeks to establish a clearer route for bringing drugs manufactured in space to market safely. The collaboration between the Civil Aviation Authority, the Medicines and Healthcare Products Regulatory Agency, the Regulatory Innovation Office, and the UK Space Agency will provide a supportive regulatory environment for space, biopharma, and pharmaceutical companies < href='https://who.int' target='_blank'>WHO research suggests that the low gravity environment in space can significantly improve the formulation of biologics and protein-based drugs.
<3> The Benefits of Microgravity
Microgravity conditions in space can improve drug solubility, purity, crystallisation, and stability, leading to more effective delivery and potentially lowering manufacturing risk and cost. This is particularly significant for biologics and protein-based drugs such as monoclonal antibodies, vaccines, and insulin. The UK Space Agency has provided funding for three in-orbit manufacturing studies, including £250,000 to London-based companies to explore the feasibility of space-based pharmaceutical manufacturing < href='https://nature.com'